Roche’s Actemra/RoActemra receives FDA EUA for the treatment of COVID-19
The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients
The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients
VITROS Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies
Top talks and new resources detailing key developments in the fields of clinical research and diagnostics are now available on demand
Watch exclusive interviews with leading industry experts on the importance of precision cold storage equipment
Watch this on-demand webinar to learn how an advanced spatial analysis workflow can be used to analyze the infiltration of CD8 positive cells across the tumor-stroma interface
The new XIENCE Skypoint stent received FDA approval in the U.S. and CE Mark approval in Europe
In this guest editorial, Michaël van der Jagt, CEO of Parx Materials, discusses how the human immune system can inspire innovation
The clinical data for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test demonstrated 100% sensitivity
Scientific, technological and communications excellence has been celebrated at the Clinical Science Summit, with Beckman Coulter, Zymo Research, and PerkinElmer among those recognized
Learn about the large scale COVID-19 PCR testing program set up by the government of Luxembourg
Updated version of highly sensitive and accurate COVID-19 PCR kit accounts for known and future viral mutations
Dr. Vikramsingh Gujar, from Northwestern University, discusses his research on inflammatory disorders and why effective knowledge share is vital for scientific advancement
The assay is fueling discovery in preserved tissue samples to advance clinical translational research
The first-of-its-kind steerable delivery system is designed to seal the left atrial appendage in people who are at increased risk of stroke due to atrial fibrillation
OncoHost’s AI-Based proteomic profiling platform, PROphet, to serve key role in host response evaluation of late-stage disease patients